Is Vytrus Biotech SA halal to invest in?

According to Musaffa's Shariah screening methodology, Vytrus Biotech SA (VYT.MC) is currently classified as HALAL as of September 2023. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Vytrus Biotech SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Vytrus Biotech SA using these criteria to determine its compliance status.

Can Muslims buy shares of Vytrus Biotech SA?

Muslim investors may consider investing in Vytrus Biotech SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Vytrus Biotech SA classified as HALAL?

Musaffa determines the Shariah status of Vytrus Biotech SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Vytrus Biotech SA updated?

The Shariah compliance status of Vytrus Biotech SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Vytrus Biotech SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Vytrus Biotech SA?

You can check the latest Shariah compliance status of Vytrus Biotech SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

VYT.MC Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: September 06, 2023

Report Source: 2022 Annual Report

Vytrus Biotech SA. Stock Analysis VYT.MC

Spain Consumer Staples Micro Cap Report: 2022 Annual

Vytrus Biotech SA is a biotechnology company, which engages in the development of cosmetic active ingredients from plant stem cell technology. The company is headquartered in Terrassa, Barcelona and currently employs 41 full-time employees. The company went IPO on 2022-03-24. The firm develops high added value natural active ingredients on an industrial scale and provides ingredients and recombinant proteins for its use in the cosmetics and pharmaceutical sectors. The Company’s technology is based on using plant cell cultures to produce bioactive molecules. The firm obtains plant cells, known as Plant Stem Cell technology, which is applicable for cosmetics. Vytrus Biotech specifically target dermo-cosmetics as well as veterinary medicine, functional food and other pharmaceuticals, generating savings of more than 99% in natural resources.

Key Statistics of Vytrus Biotech SA (VYT.MC)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€19.20€20.00

Today's Open

€19.40

Volume

9512.00

P/E Ratio (TTM)

146.79

52 Week Range

€6.30€20.60

Market Cap

72.29M

Avg. Volume

13.05K

Dividend Yield

Financial Metrics & Statements of Vytrus Biotech SA (VYT.MC)

FAQ's for Vytrus Biotech SA (VYT.MC)

According to Musaffa’s Shariah screening methodology, Vytrus Biotech SA (VYT.MC) is currently classified as HALAL as of September 2023. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.